Q4 2014

Source filing unavailable

Q4 2014 · —

derived · Computed from the longer spans the company filed.

Revenue—

Net income—

EPS, diluted—Not derived. Share counts vary by quarter.

Operating Cash Flowderived-$289,518—

Free Cash Flowderived-$291,036—

Same quarter

no prior Q4 2013 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Panacea Life Sciences Holdings, Inc. · CIK 1552189 · Engraved from SEC EDGAR